OK Biotech Co., Ltd. (TPE:4155)
Taiwan
· Delayed Price · Currency is TWD 13.90
+0.15 (1.09%)
Mar 10, 2026, 10:35 AM CST
OK Biotech Revenue
OK Biotech had revenue of 379.58M TWD in the quarter ending September 30, 2025, a decrease of -17.17%. This brings the company's revenue in the last twelve months to 1.64B, up 7.49% year-over-year. In the year 2024, OK Biotech had annual revenue of 1.67B with 40.11% growth.
Revenue (ttm)
1.64B
Revenue Growth
+7.49%
P/S Ratio
1.19
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.67B | 478.05M | 40.11% |
| Dec 31, 2023 | 1.19B | -291.54M | -19.65% |
| Dec 31, 2022 | 1.48B | 220.15M | 17.43% |
| Dec 31, 2021 | 1.26B | -221.04M | -14.89% |
| Dec 31, 2020 | 1.48B | 243.16M | 19.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diamond Biotechnology | 698.11M |
| Taiwan Biomaterial | 203.27M |
| Rossmax International | 3.80B |
| Wellell | 2.39B |
| Dynamic Medical Technologies | 1.43B |
| Applied BioCode | 443.69M |
| Bioptik Technology Incorporation | 837.19M |
| Cowealth Medical Holding | 3.41B |